As shown in Fig. 1b–d, the expression level of DLX6-AS1 in the lymph node metastasis negative group, low TNM stages group or well/moderate group was lower than that in the lymph node metastasis positive, high TNM stages or poor differentiated groups. This evidence concerns the gene DLX6 and metastatic malignant neoplasm in the lymph nodes.